|

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

RECRUITINGSponsored by The University of Texas Health Science Center at San Antonio
Actively Recruiting
SponsorThe University of Texas Health Science Center at San Antonio
Started2018-10-16
Est. completion2028-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03655015

Summary

Create a living biobank of PDOs from Stage I-III lung cancer patients.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Read, consented to and signed the IRB-approved informed consent form prior to any study related procedure.
* Diagnosis of lung cancer or lung mass or lymphadenopathy that will either systemic treatment or tumor resection as part of standard of care
* Any clinical stage of lung cancer
* Adult patients ≥18 years of age
* Able and willing to complete a questionnaire on their environmental/occupational exposures and smoking/alcohol history

Exclusion Criteria:

* At the discretion of the treating physician, patient will not be able to fulfill the requirements of the study.

Conditions3

CancerLung CancerLung Neoplasm

Locations1 site

UT Health San Antonio, M.D. Anderson Cancer Center
San Antonio, Texas, 78229
Epp GoodwinCTRCReferral@uthscsa.edu

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.